EUVIMEDEUVIMED entdecken
KohortenstudieQuerschnittstudieStudienprotokollOpen Access

Screening and Risk Analysis of Atrial Fibrillation After Radiotherapy for Breast Cancer: Protocol for the Cross-Sectional Cohort Study “Watch Your Heart (WATCH)”

Laura Saint-Lary iD, Baptiste Pinel iD, Loic Panh iD, Gaelle Jimenez iD, Julien Geffrelot iD, Youlia Kirova iD, Jeremy Camilleri iD, David Broggio iD, Marie-Odile Bernier iD, Corinne Mandin iD, Christelle Levy iD, Serge Boveda iD und 2 weitere

JMIR Research Protocols · 2025

DOI: 10.2196/67875 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Laura Saint-Lary und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Epidemiology, Autorité de Sûreté Nucléaire et Radioprotection, Fontenay-aux-Roses, France. Hauptthemen laut MEDLINE: Atrial Fibrillation, Breast Neoplasms, Radiotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation (AF) after radiotherapy (RT) in patients with breast cancer (BC) is a relatively new and understudied topic. AF can increase the risk of stroke and other serious cardiovascular complications, compromising patients’ quality of life and survival. Screening of AF, both asymptomatic and symptomatic forms, is therefore essential for optimal management.

Objective

The aim of the Watch Your Heart After Radiotherapy for Breast Cancer (WATCH) study is to assess the incidence of AF (symptomatic or asymptomatic) occurring throughout a 5-year follow-up after RT and to investigate whether cardiac radiation exposure is associated with the occurrence of such events.

Methods

WATCH is a cohort study that will include 200 patients over 65 years old, treated with RT for BC 5 years before inclusion and without a history of AF. Cross-sectional screening for AF at the time of the scheduled 5-year post-RT visit will be conducted by recording data from a Withings ScanWatch smartwatch for 1 month, confirmed by an electrocardiogram (ECG), and validated by a physician. In addition, a transthoracic echocardiography (TTE) will be performed, providing a comprehensive assessment of cardiac structures, and allowing us to investigate the underlying etiology and assess the risk of complications. Patients’ medical records will provide retrospective information about the timing and risk factors for the occurrence of AF and other arrhythmias and cardiac diseases during the 5 years following RT. The development of deep learning algorithms for autosegmentation analysis of potentially critical substructures for the occurrence of AF, including cardiac chambers, the sinoatrial node, the atrioventricular node, coronary arteries, and pulmonary veins (PVs), will produce dosimetry linked to previous RT treatment for all contoured structures.

Results

Enrollment started in October 2023 and will continue until mid-2026 to include 200 patients, which will ensure an 80% statistical power to detect a significant difference in AF incidence around 15% for the group of patients moderately exposed (75th percentile of the mean heart radiation dose). The results are expected by the end of 2026.

Conclusions

This study will contribute to generating new knowledge on AF after RT for BC and help considering the inclusion of AF screening into routine clinical practice for these patients. Identifying the dose-risk associations would improve RT delivery protocols to limit the occurrence of different forms of AF and, if necessary, initiate appropriate treatment. Trial Registration ClinicalTrials.gov NCT06073509; clinicaltrials.gov/study/NCT06073509?id=NCT06073509&rank=1. International Registered Report Identifier (IRRID) DERR1-10.2196/67875

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationBreast NeoplasmsRadiotherapyAgedFemaleHumansCohort StudiesCross-Sectional StudiesEchocardiographyElectrocardiographyIncidenceMass ScreeningRisk AssessmentRisk FactorsObservational Studies as Topic

Stichwörter der Autor:innen

arrhythmiaatrial fibrillationbreast cancercardiac dosimetryradiotherapysmartwatch

Autor:innen und Institutionen

  • Laboratory of Epidemiology, Autorité de Sûreté Nucléaire et Radioprotection, Fontenay-aux-Roses, France.
  • Department of Radiation Oncology, Clinique Pasteur, Toulouse, France.
  • Department Heart Rhythm Management, Cardiology, Clinique Pasteur, Toulouse, France.
  • Department of Radiation Oncology, Centre François Baclesse, Caen, France.
  • Department of Radiation Oncology, Institut Curie, Paris, France.
  • Department of Dosimetry, Autorité de sûreté nucléaire et de radioprotection, Fontenay-aux-Roses, France.

ORCID-Profile: Laura Saint-Lary, Baptiste Pinel, Loic Panh, Gaelle Jimenez, Julien Geffrelot, Youlia Kirova, Jeremy Camilleri, David Broggio, Marie-Odile Bernier, Corinne Mandin, Christelle Levy, Serge Boveda, Juliette Thariat, Sophie Jacob

Zitieren

APA

Saint-Lary, L., Pinel, B., Panh, L., Jimenez, G., Geffrelot, J., Kirova, Y., Camilleri, J., Broggio, D., Bernier, M. O., Mandin, C., Levy, C., Boveda, S., Thariat, J., & Jacob, S. (2025). Screening and Risk Analysis of Atrial Fibrillation After Radiotherapy for Breast Cancer: Protocol for the Cross-Sectional Cohort Study “Watch Your Heart (WATCH)”. JMIR Research Protocols. https://doi.org/10.2196/67875

Vancouver

Saint-Lary L, Pinel B, Panh L, Jimenez G, Geffrelot J, Kirova Y, et al. Screening and Risk Analysis of Atrial Fibrillation After Radiotherapy for Breast Cancer: Protocol for the Cross-Sectional Cohort Study “Watch Your Heart (WATCH)”. JMIR Research Protocols. 2025. doi:10.2196/67875

BibTeX
@article{SaintLary2025,
  author = {Saint-Lary, Laura and Pinel, Baptiste and Panh, Loic and Jimenez, Gaelle and Geffrelot, Julien and Kirova, Youlia and Camilleri, Jeremy and Broggio, David and Bernier, Marie-Odile and Mandin, Corinne and Levy, Christelle and Boveda, Serge and Thariat, Juliette and Jacob, Sophie},
  title = {Screening and Risk Analysis of Atrial Fibrillation After Radiotherapy for Breast Cancer: Protocol for the Cross-Sectional Cohort Study “Watch Your Heart (WATCH)”},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/67875}
}
Kostenlos starten →